Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010 (2010), Article ID 121094, 8 pages
http://dx.doi.org/10.1155/2010/121094
Research Article

Construction and Characterization of a Novel Fusion Protein MG7-scFv/SEB against Gastric Cancer

Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Avenue, Wuhan 430022, China

Received 20 September 2009; Revised 4 January 2010; Accepted 13 January 2010

Academic Editor: Xin-yuan Guan

Copyright © 2010 Qiang Tong et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Garcia, A. Jemal, E. M. Ward, M. M. Center, Y. Hao, and R. L. Siegel, Global Cancer Facts and Figures 2007, American Cancer Society, Atlanta, Ga, USA, 2007.
  2. F. Kamangar, G. M. Dores, and W. F. Anderson, “Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world,” Journal of Clinical Oncology, vol. 24, no. 14, pp. 2137–2150, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Pinto, F. Di Fabio, S. Siena et al., “Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study),” Annals of Oncology, vol. 18, no. 3, pp. 510–517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. G. R. Thrush, L. R. Lark, B. C. Clinchy, and E. S. Vitetta, “Immunotoxins: an update,” Annual Review of Immunology, vol. 14, pp. 49–71, 1996. View at Publisher · View at Google Scholar · View at Scopus
  5. T. A. Waldmann, “Monoclonal antibodies in diagnosis and therapy,” Science, vol. 252, no. 5013, pp. 1657–1662, 1991. View at Google Scholar · View at Scopus
  6. G. Hedlund, M. Dohlsten, C. Petersson, and T. Kalland, “Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells,” Cancer Immunology, Immunotherapy, vol. 36, no. 2, pp. 89–93, 1993. View at Publisher · View at Google Scholar · View at Scopus
  7. N. Intasai, K. Tragoolpua, P. Pingmuang et al., “Potent inhibition of OKT3-induced T cell proliferation and suppression of CD147 cell surface expression in HeLa cells by scFv-M6-1B9,” Immunobiology, vol. 214, no. 6, pp. 410–421, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Zhang, S. Zhang, N.-K. V. Cheung, G. Ragupathi, and P. O. Livingston, “Antibodies against GD2 ganglioside can eradicate syngeneic cancer micrometastases,” Cancer Research, vol. 58, no. 13, pp. 2844–2849, 1998. View at Google Scholar · View at Scopus
  9. D. Colcher, A. Goel, G. Pavlinkova, G. Beresford, B. Booth, and S. K. Batra, “Effects of genetic engineering on the pharmacokinetics of antibodies,” Quarterly Journal of Nuclear Medicine, vol. 43, no. 2, pp. 132–139, 1999. View at Google Scholar · View at Scopus
  10. R. K. Jain, “Transport of molecules across tumor vasculature,” Cancer and Metastasis Review, vol. 6, no. 4, pp. 559–593, 1987. View at Publisher · View at Google Scholar · View at Scopus
  11. D. E. Milenic, T. Yokota, D. R. Filpula et al., “Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49,” Cancer Research, vol. 51, no. 23, pp. 6363–6371, 1991. View at Google Scholar · View at Scopus
  12. G. P. Adams, J. E. McCartney, M.-S. Tai et al., “Highly specific in vivo tumor targeting by monovalent and divalent forms of 741F8 anti-c-erbB-2 single-chain Fv,” Cancer Research, vol. 53, no. 17, pp. 4026–4034, 1993. View at Google Scholar · View at Scopus
  13. G. Pavlinkova, G. W. Beresford, B. J. M. Booth, S. K. Batra, and D. Colcher, “Pharmacokinetics and biodistribution of engineered single-chain antibody constructs of MAb CC49 in colon carcinoma xenografts,” Journal of Nuclear Medicine, vol. 40, no. 9, pp. 1536–1546, 1999. View at Google Scholar · View at Scopus
  14. U. A. Wittel, M. Jain, A. Goel et al., “Engineering and characterization of a divalent single-chain Fv angiotensin II fusion construct of the monoclonal antibody CC49,” Biochemical and Biophysical Research Communications, vol. 329, no. 1, pp. 168–176, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Goel, D. Colcher, J. Baranowska-Kortylewiez et al., “Genetically engineered tetravalent single-chain Fv of the pancarcinoma monoclonal antibody CC49: improved biodistribution and potential for therapeutic application,” Cancer Research, vol. 60, no. 24, pp. 6964–6971, 2000. View at Google Scholar · View at Scopus
  16. A. L. M. Oei, F. C. G. J. Sweep, L. F. A. G. Massuger, A. J. Olthaar, and C. M. G. Thomas, “Transient human anti-mouse antibodies (HAMA) interference in CA 125 measurements during monitoring of ovarian cancer patients treated with murine monoclonal antibody,” Gynecologic Oncology, vol. 109, no. 2, pp. 199–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Yokota, D. E. Milenic, M. Whitlow, and J. Schlom, “Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms,” Cancer Research, vol. 52, no. 12, pp. 3402–3408, 1992. View at Google Scholar · View at Scopus
  18. A. A. McCormick, S. Reddy, S. J. Reinl et al., “Plant-produced idiotype vaccines for the treatment of non-Hodgkin's lymphoma: safety and immunogenicity in a phase I clinical study,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 29, pp. 10131–10136, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. E. Bird, K. D. Hardman, J. W. Jacobson et al., “Single-chain antigen-binding proteins,” Science, vol. 241, no. 4877, pp. 423–426, 1988. View at Google Scholar · View at Scopus
  20. G. P. Adams and R. Schier, “Generating improved single-chain Fv molecules for tumor targeting,” Journal of Immunological Methods, vol. 231, no. 1-2, pp. 249–260, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. P. J. Yazaki, T. Kassa, C. Cheung et al., “Biodistribution and tumor imaging of an anti-CEA single-chain antibody-albumin fusion protein,” Nuclear Medicine and Biology, vol. 35, no. 2, pp. 151–158, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. D. N. Krag, G. S. Shukla, G.-P. Shen et al., “Selection of tumor-binding ligands in cancer patients with phage display libraries,” Cancer Research, vol. 66, no. 15, pp. 7724–7733, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Hedlund, M. Dohlsten, C. Petersson, and T. Kalland, “Superantigen-based tumor therapy: in vivo activation of cytotoxic T cells,” Cancer Immunology Immunotherapy, vol. 36, no. 2, pp. 89–93, 1993. View at Publisher · View at Google Scholar · View at Scopus
  24. B. A. Torres, S. Kominsky, G. Q. Perrin, A. C. Hobeika, and H. M. Johnson, “Superantigens: the good, the bad, and the ugly,” Experimental Biology and Medicine, vol. 226, no. 3, pp. 164–176, 2001. View at Google Scholar · View at Scopus
  25. J. White, A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack, “The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice,” Cell, vol. 56, no. 1, pp. 27–35, 1989. View at Google Scholar · View at Scopus
  26. J. K. Russell, C. H. Pontzer, and H. M. Johnson, “The I-Aβb region (65–85) is a binding site for the superantigen, staphylococcal enterotoxin A,” Biochemical and Biophysical Research Communications, vol. 168, no. 2, pp. 696–701, 1990. View at Publisher · View at Google Scholar · View at Scopus
  27. J. K. Russell, C. H. Pontzer, and H. M. Johnson, “Both α-helices along the major histocompatibility complex binding cleft are required for staphylococcal enterotoxin A function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 16, pp. 7228–7232, 1991. View at Google Scholar · View at Scopus
  28. K. Mehindate, J. Thibodeau, M. Dohlsten, T. Kalland, R.-P. Sékaly, and W. Mourad, “Cross-linking of major histocompatibility complex class II molecules by staphylococcal enterotoxin A superantigen is a requirement for inflammatory cytokine gene expression,” Journal of Experimental Medicine, vol. 182, no. 5, pp. 1573–1577, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. H. Fischer, M. Dohlsten, U. Andersson et al., “Production of TNF-a and TNF-ß by staphylococcal enterotoxin A activated human T cells,” Journal of Immunology, vol. 144, no. 12, pp. 4663–4669, 1990. View at Google Scholar · View at Scopus
  30. F. G. E. Perabo, P. L. Willert, A. Wirger, D. H. Schmidt, A. von Ruecker, and S. C. Mueller, “Superantigen-activated mononuclear cells induce apoptosis in transitional cell carcinoma,” Anticancer Research, vol. 25, no. 5, pp. 3565–3573, 2005. View at Google Scholar · View at Scopus
  31. L. Wang, H. Zhang, S. Zhang, M. Yu, and X. Yang, “Construction and characterization of a novel superantigen fusion protein: BFGF/SEB,” Cancer Investigation, vol. 27, no. 4, pp. 376–383, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. F. G. E. Perabo, P. L. Willert, A. Wirger et al., “Preclinical evaluation of superantigen (staphylococcal enterotoxin B) in the intravesical immunotherapy of superficial bladder cancer,” International Journal of Cancer, vol. 115, no. 4, pp. 591–598, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. Z.-C. Yu, J. Ding, B.-R. Pan, D.-M. Fan, and X.-Y. Zhang, “Expression and bioactivity identification of soluble MG7 scFv,” World Journal of Gastroenterology, vol. 8, no. 1, pp. 99–102, 2002. View at Google Scholar · View at Scopus
  34. S. T. Gao, R. L. Zhang, H. J. Liu et al., “Sub-cloning of the enterotoxin B gene from a wild Staphylococcus aureus strain and its expression in Escherichia coli,” Journal of Pathogen Biology, vol. 2, no. 6, pp. 413–416, 2007. View at Google Scholar
  35. S. Swaminathan, W. Furey, J. Pletcher, and M. Sax, “Crystal structure of staphylococcal enterotoxin B, a superantigen,” Nature, vol. 359, no. 6398, pp. 801–806, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. J. Ren, Z. Chen, S. J. Zhou, X. Y. Zhang, B. R. Pan, and D. M. Fan, “Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno-polymerase chain reaction technique,” Cancer, vol. 88, no. 2, pp. 280–285, 2000. View at Publisher · View at Google Scholar · View at Scopus
  37. D.-L. Guo, M. Dong, L. Wang, L.-P. Sun, and Y. Yuan, “Expression of gastric cancer-associated MG7 antigen in gastric cancer, precancerous lesions and H. pylori-associated gastric diseases,” World Journal of Gastroenterology, vol. 8, no. 6, pp. 1009–1013, 2002. View at Google Scholar · View at Scopus